News Release Details
Entegris Expands Life Sciences Production Capacity and Capabilities
The expansion of production facilities and development of a dedicated
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210607005519/en/
Entegris' Aramus™ critical fluid handling product line is used to produce and deliver vaccines worldwide like the COVID-19 vaccines. Photo credit:
The expansions are part of Entegris’ capital expenditures plan to invest approximately
Entegris also has started development of its
“With more than 50 years of experience serving industries with complex specifications, we understand the importance of process stability, consistency, safety and speed in bioprocessing. Entegris’ life sciences solutions have proven to be invaluable to biopharmaceutical companies in successfully delivering COVID-19 vaccines to the global population. Our investment in expanding and developing facilities dedicated to life sciences capabilities further demonstrates the company's commitment to effectively serving this industry – now and in the future.”
The expansion of Entegris’ bioprocessing facilities comes as the pharmaceutical sector increases demand for high-purity systems designed for freezing, transporting, storing, and thawing drug substances. In addition to COVID-19 vaccines, these solutions are also applicable in the production of other treatments and therapeutics.
In addition to the Aramus 2D bag product line, Entegris provides other clean, scalable, and reliable bioprocessing solutions capable of reducing validation time, development costs, and time-to-market. Products include specialty and fine chemicals, fluid management technologies, particle characterization, liquid packaging, process analytics, filtration, and purification.
To learn about how Entegris is supporting the life sciences sector, visit www.entegris.com/life-sciences.
Entegris is a world-class supplier of advanced materials and process solutions for the semiconductor and other high-technology industries. Entegris has approximately 5,800 employees throughout its global operations and is ISO 9001 certified. It has manufacturing, customer service, and/or research facilities in
This news release contains forward-looking statements. The words “believe,” “expect,” “anticipate,” “intend,” “estimate,” “forecast,” “project,” “should,” “may,” “will,” “would” or the negative thereof and similar expressions are intended to identify such forward-looking statements. These forward-looking statements include statements related to future investments in capabilities and capacity; demand expectations for Entegris’ products; expected staffing levels; and other matters. These statements involve risks and uncertainties, and actual results may differ materially from those projected in the forward-looking statements. These risks and uncertainties include, but are not limited to, those risk factors and additional information described in Entegris’ filings with the
Director of Corporate Communications
T +1 978-436-6546
VP of Investor Relations
T +1 952-556-1844